Effect of Interleukin-18 on Viral Myocarditis: Enhancement of Interferon- γ and Natural Killer Cell Activity
Authors:
- 31 December 2000
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 32 (12) , 2163-2171
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effects of Intranasal Administration of Recombinant Murine Interferon-γ on Murine Acute Myocarditis Caused by Encephalomyocarditis VirusCirculation, 1998
- Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.Journal of Clinical Investigation, 1998
- Persistent Expression of Cytokine in the Chronic Stage of Viral Myocarditis in MiceCirculation, 1996
- Modification of Viral Myocarditis in Mice by Interleukin-6Circulation Research, 1996
- Interferon and thymic hormones in the therapy of human myocarditis and idiopathic dilated cardiomyopathyEuropean Heart Journal, 1995
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.Circulation, 1994
- A Major Role of Macrophage Activation by Interferon-Gamma during Mouse Hepatitis Virus Type 3 Infection. I. Genetically Dependent ResistanceImmunobiology, 1989
- Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferonJournal of Molecular and Cellular Cardiology, 1985
- Cloning and expression of murine immune interferon cDNA.Proceedings of the National Academy of Sciences, 1983